Related Experiment Videos
Active specific immunotherapy of human solid tumors
Virginia Medical
|March 1, 1978
Abstract:
A limited study of tumor patients with otherwise untreatable lesions suggests the feasibility of using enzyme altered cells in the active specific immunotherapy of human solid tumors.
Insights
Enzyme altered cells show promise for treating human solid tumors when other options fail. This active immunotherapy approach appears feasible for patients with untreatable lesions.
Area of Science:
- Oncology
- Immunotherapy
- Cellular Therapy
Background:
- Solid tumors represent a significant challenge in cancer treatment.
- Current therapeutic options for advanced or untreatable solid tumors are limited.
- Active specific immunotherapy offers a potential alternative treatment strategy.
Purpose of the Study:
- To investigate the feasibility of using enzyme altered cells for active specific immunotherapy.
- To evaluate this approach in patients with otherwise untreatable human solid tumors.
Main Methods:
- A limited study was conducted involving patients with specific types of solid tumors.
- The core method involved the administration of enzyme altered cells as an immunotherapy agent.
Main Results:
- The study suggests that using enzyme altered cells is a feasible approach.
- Preliminary findings indicate potential for active specific immunotherapy in human solid tumors.
Conclusions:
- Enzyme altered cells demonstrate feasibility for active specific immunotherapy.
- This approach may offer a viable treatment option for patients with untreatable solid tumors.